# Goldman Sachs BDC, Inc.: overview GSBD · NYSE · CIK 1572694 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/gsbd.md) · [Financials](/companies/gsbd/financials.md) · [Filings](/companies/gsbd/filings.md) · [Insiders](/companies/gsbd/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.32](/filings/0001193125-25-269840.md) | not reported | [0.27](/filings/0001193125-26-212431.md) | [0.34](/filings/0001193125-26-338331.md) | [0.22](/filings/0001193125-25-269840.md) | not reported | [(0.12)](/filings/0001193125-26-212431.md) | [0.21](/filings/0001193125-26-338331.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [1.89](/filings/0000950170-24-022198.md) | [0.54](/filings/0000950170-25-029231.md) | [1.81](/filings/0001193125-26-077458.md) | [0.55](/filings/0001193125-26-077458.md) | [1.03](/filings/0001193125-26-077458.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:ProfitLoss; Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/gsbd/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [GOLDMAN SACHS GROUP INC](/funds/886982.md) | 2026-06-30 | $62.0m | 6,535,509 | | Unchanged | | [PRIVATE MANAGEMENT GROUP INC](/funds/1142031.md) | 2026-06-30 | $49.1m | 5,178,638 | | Added +175,284 | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $44.7m | 4,713,836 | | Added +1,083,863 | | [Generali Asset Management SPA SGR](/funds/2046751.md) | 2026-06-30 | $31.2m | 3,294,022 | | Unchanged | | [ARES MANAGEMENT LLC](/funds/1259313.md) | 2026-06-30 | $29.8m | 3,147,251 | | Added +976,078 | | [VAN ECK ASSOCIATES CORP](/funds/869178.md) | 2026-06-30 | $25.4m | 2,676,020 | | Added +607,997 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $24.4m | 2,577,113 | | Added +49,217 | | [Lunate Capital Ltd](/funds/2056786.md) | 2026-06-30 | $20.8m | 2,192,392 | | New +2,192,392 | | [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $16.0m | 1,689,253 | | Added +42,317 | | [Lalia Capital, LLC](/funds/2106818.md) | 2026-06-30 | $11.3m | 1,193,406 | | New +1,193,406 | ## Recent filings [All 601 filings](/companies/gsbd/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-05 | 20:39 ET | [8-K](/filings/0001193125-26-414262.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-414262 | | 2026-08-07 | 21:56 ET | [8-K](/filings/0001193125-26-338524.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-338524 | | 2026-08-06 | 20:50 ET | [10-Q](/filings/0001193125-26-338331.md) | Quarterly report, period 2026-06-30 | 0001193125-26-338331 | | 2026-07-07 | 21:14 ET | [8-K](/filings/0001193125-26-297641.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-297641 | | 2026-05-28 | 20:12 ET | [8-K](/filings/0001193125-26-245245.md) | 5.07 Shareholder vote results | 0001193125-26-245245 | | 2026-05-08 | 23:38 ET | [8-K](/filings/0001193125-26-212714.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-212714 | | 2026-05-07 | 21:19 ET | [10-Q](/filings/0001193125-26-212431.md) | Quarterly report, period 2026-03-31 | 0001193125-26-212431 | | 2026-04-14 | 21:14 ET | [8-K](/filings/0001193125-26-155098.md) | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-155098 | | 2026-04-01 | 20:59 ET | [DEF 14A](/filings/0001193125-26-138148.md) | Proxy statement, period 2026-05-27 | 0001193125-26-138148 | | 2026-03-17 | 20:23 ET | [8-K](/filings/0001193125-26-110886.md) | 5.02 Departure or appointment of officers or directors | 0001193125-26-110886 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001193125-26-077458.md), filed Feb 26, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1572694 - Tickers: GSBD - Exchange: NYSE - SIC code: not reported - State of incorporation: DE - Filer category: Large accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:43 ET. No prices; not investment advice.